What is the appropriate dosing interval for ceftazidime in a patient on thrice‑weekly hemodialysis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 6, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Ceftazidime Dosing Interval for Thrice-Weekly Hemodialysis

For patients on thrice-weekly hemodialysis, administer 1 gram of ceftazidime after each dialysis session (i.e., every 48-72 hours post-dialysis). 1

FDA-Approved Dosing Regimen

The FDA label explicitly recommends the following for hemodialysis patients 1:

  • Loading dose: 1 gram of ceftazidime
  • Maintenance dose: 1 gram after each hemodialysis period
  • This applies to the standard thrice-weekly hemodialysis schedule

Pharmacokinetic Rationale

Ceftazidime is eliminated almost exclusively by glomerular filtration (80-90% excreted unchanged in urine), making dosage adjustment critical in renal impairment 1. Key pharmacokinetic considerations include:

  • Hemodialysis removes 55% of the administered dose during a 4-hour session 2
  • The elimination half-life extends from 1.9 hours in normal renal function to approximately 33.6 hours in anuric patients 2
  • Post-dialysis dosing ensures therapeutic concentrations are restored after drug removal 1

Evidence Supporting the 1-Gram Post-Dialysis Dose

For 48-hour interdialytic intervals:

  • 1 gram post-hemodialysis achieves >90% probability of target attainment (PTA) for organisms with MIC ≤8 μg/mL 3
  • This dose maintains 100% time above MIC (%T>MIC) throughout the 48-hour interval 4

For 72-hour interdialytic intervals:

  • 1 gram post-hemodialysis achieves adequate PTA only for organisms with MIC ≤4 μg/mL 3
  • If treating more resistant organisms (MIC 8 μg/mL) with 72-hour intervals, consider 2 grams post-dialysis 3
  • Alternatively, add a supplemental 500 mg dose at the 48-hour mark during the 72-hour interval 5

Alternative Daily Dosing Strategy

Recent evidence suggests that daily dosing of 500 mg to 1 gram (regardless of dialysis schedule) may provide superior coverage 3, 6:

  • 500 mg once daily achieves 90% PTA for organisms with MIC ≤16 μg/mL 3
  • 1 gram once daily may achieve 100% PTA even for resistant organisms with MIC 32 μg/mL 3
  • This approach is preferable when MIC data are unavailable or for critically ill patients 3

Critical Considerations

Dialysis modality matters:

  • The above recommendations apply specifically to low-flux or high-flux hemodialysis 4, 3
  • High-flux dialysis removes more drug than low-flux, but the 1-gram post-dialysis dose remains adequate for both 4, 3

Infection severity and pathogen MIC:

  • For serious infections (meningitis, severe sepsis) or organisms with higher MICs, consider the 2-gram post-dialysis dose 1
  • For uncomplicated infections with susceptible organisms (MIC ≤4 μg/mL), 1 gram post-dialysis is sufficient 4, 3

Anuric vs. non-anuric patients:

  • The 1-gram post-dialysis regimen is validated primarily in anuric patients 4, 2
  • Non-anuric patients with residual renal function may require dose adjustments, though specific data are limited 4

Common Pitfall to Avoid

Do not dose ceftazidime on non-dialysis days using the standard every-8-hour or every-12-hour schedule in patients on intermittent hemodialysis. The prolonged half-life (33.6 hours) in anuric patients means drug accumulation will occur, increasing neurotoxicity risk 2. The post-dialysis dosing strategy accounts for both the extended half-life and dialytic removal 1, 2.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.